Alvotech reports financial results for first quarter of 2024 and provides a business update

Reykjavik, iceland, may 21, 2024 (globe newswire) -- alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first three months of 2024 and provided a summary of recent corporate highlights.
ALVO Ratings Summary
ALVO Quant Ranking